Flowserve
FLS
$71.66
+4.48%
Flowserve Corporation is a leading manufacturer and aftermarket service provider of precision-engineered flow control systems, including pumps, valves, seals, and services for industries such as oil and gas, chemical, power generation, and water management. As a market leader in the flow control industry, Flowserve distinguishes itself through its comprehensive product portfolio and global aftermarket service network. The current investor narrative centers on the company's ability to navigate cyclical end-market demand, with recent attention on its margin improvement initiatives and the impact of large project awards on future revenue growth, despite a near-term revenue decline in the most recent quarter.…
FLS
Flowserve
$71.66
Investment Opinion: Should I buy FLS Today?
Rating: Buy. Thesis: Flowserve's attractive forward valuation (P/E 14.83x), improving margins, and strong analyst consensus (Buy, 29.3% upside) make it a compelling investment for those willing to tolerate near-term cyclical weakness.
Supporting Evidence: The forward P/E of 14.83x is well below the trailing 26.08x, implying expected earnings growth. Revenue is expected to recover to $5.78 billion (analyst estimate), up from the current run rate. Gross margin improved to 37.1% in Q1 2026 from 34.6% in Q3 2025, and operating margin of 13.6% is healthy. Free cash flow TTM of $436.7M supports dividends and capex. The average analyst target of $88.50 implies 29.3% upside, with a high target of $100 (46% upside).
Risks & Conditions: Key risks include further revenue deceleration, margin compression, and negative earnings surprises. This Buy rating would be downgraded to Hold if revenue growth fails to turn positive in the next two quarters or if gross margin falls below 35%. The stock appears undervalued relative to its forward earnings potential and analyst targets, but fairly valued on a trailing basis.
Sign up to view all
FLS 12-Month Price Forecast
The AI assessment is bullish on FLS with medium confidence. The key factors supporting this stance are the attractive forward P/E (14.83x) relative to trailing (26.08x), strong analyst consensus (Buy, 29.3% upside), and improving gross margins (37.1%). However, the recent revenue decline (-6.66% YoY) and negative price momentum (-13.26% in 1 month) temper confidence. The base case of gradual recovery is most likely, but if revenue growth accelerates, the bull case could materialize. A downgrade would occur if revenue continues to decline or margins deteriorate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Flowserve's 12-month outlook, with a consensus price target around $88.50 and implied upside of +23.5% versus the current price.
Average Target
$88.50
0 analysts
Implied Upside
+23.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $100
Analyst target range
Flowserve is covered by 10 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.82 (where 1 is Strong Buy and 5 is Sell). The average target price is $88.50, implying a substantial 29.3% upside from the current price of $68.46. The distribution shows a bullish lean, with no sell ratings and a majority of buy or outperform ratings. The high target of $100.00 suggests potential for a 46% upside, likely assuming a recovery in end-markets and margin expansion, while the low target of $70.00 implies only a 2.2% upside, reflecting downside risks from cyclical weakness. The wide spread between low and high targets ($30) indicates high uncertainty about the near-term outlook. Recent ratings actions include a downgrade from TD Cowen from Buy to Hold on June 24, 2026, which may have contributed to the recent price weakness. However, other firms like RBC Capital, Stifel, and Citigroup have maintained positive ratings, suggesting mixed sentiment. The consensus remains bullish, but the downgrade highlights near-term caution.
Bulls vs Bears: FLS Investment Factors
Flowserve presents a mixed picture: the bull case rests on a strong analyst consensus (Buy, 29.3% upside to average target), improving gross margins (37.1% in Q1 2026), and a solid balance sheet (debt-to-equity 0.80, current ratio 2.03). The bear case highlights a recent revenue decline (-6.66% YoY), sharp price pullback (-13.26% in 1 month), earnings volatility (negative EPS in Q4 2025), and a high trailing P/E (26.08x). Currently, the bull case has stronger evidence given the attractive forward P/E (14.83x) and analyst optimism, but the key tension is whether the revenue decline is temporary or the start of a prolonged cyclical downturn. Resolution of this factor will most likely determine the stock's trajectory.
Bullish
- Strong Analyst Consensus Buy: With 10 analysts covering FLS, the consensus is 'Buy' and the mean recommendation score is 1.82 (1=Strong Buy, 5=Sell). The average target price of $88.50 implies a 29.3% upside from the current price of $68.46, indicating significant near-term appreciation potential.
- Attractive Forward Valuation: The forward P/E of 14.83x is well below the trailing P/E of 26.08x, reflecting expected earnings growth. The PEG ratio of 1.10 suggests the stock is fairly valued relative to its growth rate, and the forward P/E is near the lower end of its historical range, offering a margin of safety.
- Improving Gross Margins: Gross margin improved to 37.1% in Q1 2026 from 34.6% in Q3 2025, indicating successful cost management and pricing power. This margin expansion, if sustained, could drive significant earnings leverage as revenue recovers.
- Solid Balance Sheet and Cash Flow: Debt-to-equity is a manageable 0.80, and the current ratio of 2.03 indicates strong liquidity. Trailing twelve-month free cash flow of $436.7 million provides ample capacity for dividends (payout ratio 31.7%) and strategic investments.
Bearish
- Recent Revenue Decline: Q1 2026 revenue fell 6.66% year-over-year to $1.068 billion, with both original equipment ($457M) and aftermarket ($612M) segments declining. This contraction raises concerns about end-market demand and could signal a cyclical downturn.
- Sharp Price Pullback and Negative Momentum: The stock has declined 13.26% in the past month and 18.33% in the past three months, underperforming the S&P 500 by 13.57% and 22.99% respectively. The current price of $68.46 is near the lower end of its 52-week range, reflecting persistent selling pressure.
- Earnings Volatility and Negative EPS Quarter: Net income swung from a loss of -$29.0 million in Q4 2025 to a profit of $81.7 million in Q1 2026, highlighting earnings instability. The negative EPS in Q4 2025 (-$0.23) demonstrates the cyclical nature of the business and potential for further downside.
- High Trailing P/E and Premium Price-to-Book: The trailing P/E of 26.08x is elevated relative to the forward P/E, implying the market is pricing in a sharp earnings recovery that may not materialize. The price-to-book ratio of 4.12x is above historical averages of 2.5-3.0x, suggesting the stock is not cheap on a book value basis.
FLS Technical Analysis
Flowserve's stock is in a sustained uptrend over the past year, with a 1-year price change of +25.04%, significantly outperforming the S&P 500's +18.35% gain. However, the current price of $68.46 sits at 48.4% of its 52-week range (low $48.71, high $92.41), indicating it is closer to the lower end of the range after a sharp pullback from the highs. This positioning suggests the stock may be offering a value opportunity if the long-term uptrend resumes, but it also reflects recent selling pressure that warrants caution. Short-term momentum is decisively negative, with the 1-month price change at -13.26% and the 3-month change at -18.33%, both contrasting sharply with the positive 1-year trend. This divergence signals a significant pullback that could be a mean-reversion opportunity or the start of a trend reversal, especially given the stock's relative weakness versus the S&P 500 (relative strength -13.57% over 1 month). The RSI is not provided, but the steep decline suggests oversold conditions may be emerging. Key support lies near the 52-week low of $48.71, while resistance is at the 52-week high of $92.41. A breakdown below $48.71 would signal a major trend failure, while a recovery above $70 could indicate stabilization. With a beta of 1.247, Flowserve is about 25% more volatile than the market, amplifying both upside and downside moves, which is critical for risk management.
Beta
1.25
1.25x market volatility
Max Drawdown
-30.0%
Largest decline past year
52-Week Range
$49-$92
Price range past year
Annual Return
+30.9%
Cumulative gain past year
| Period | FLS Return | S&P 500 |
|---|---|---|
| 1m | -10.4% | +0.6% |
| 3m | -13.9% | +3.4% |
| 6m | -8.0% | +7.1% |
| 1y | +30.9% | +16.4% |
| ytd | +1.3% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FLS Fundamental Analysis
Flowserve's revenue trajectory shows a mixed picture: the most recent quarter (Q1 2026) reported revenue of $1,068 million, a year-over-year decline of -6.66%, following a pattern of fluctuating growth. Over the past four quarters, revenue has ranged from $1,068 million to $1,222 million, with the Q4 2025 quarter showing a sharp drop in net income. The revenue decline in Q1 2026 was driven by a -6.66% YoY contraction, with original equipment revenue of $457 million and aftermarket revenue of $612 million, indicating weakness in both segments. This deceleration raises concerns about end-market demand, though the company's backlog and large project pipeline may support a recovery. Profitability remains positive but uneven: net income in Q1 2026 was $81.7 million, down from $219.6 million in Q3 2025 but up from a loss of -$29.0 million in Q4 2025. Gross margin improved to 37.1% in Q1 2026 from 34.6% in Q3 2025, suggesting better cost management, while operating margin was 13.6%. The net margin of 7.6% is healthy for the industrial machinery sector, but the volatility in earnings (including a negative EPS in Q4 2025) highlights the cyclical nature of the business. Flowserve's balance sheet is solid: debt-to-equity is 0.80, and the current ratio is 2.03, indicating ample liquidity. Free cash flow over the trailing twelve months was $436.7 million, though Q1 2026 saw negative free cash flow of -$60.0 million due to working capital changes. ROE stands at 15.8%, reflecting efficient use of equity, and the company generates enough cash to cover dividends (payout ratio 31.7%) and capital expenditures, reducing reliance on external financing.
Quarterly Revenue
$1.1B
2026-03
Revenue YoY Growth
-6.7%
YoY Comparison
Gross Margin
37.1%
Latest Quarter
Free Cash Flow
$436650000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FLS Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 26.08x, while the forward P/E is 14.83x, implying the market expects significant earnings growth in the coming year. The gap between trailing and forward P/E suggests that analysts anticipate a sharp recovery in earnings, which is consistent with the estimated EPS of $5.68 for the current fiscal year. Compared to the industry average (not provided), Flowserve's trailing P/E of 26.08x appears elevated relative to the broader market, but the forward P/E of 14.83x is more reasonable. Without industry data, we note that the PEG ratio of 1.10 suggests the stock is fairly valued relative to its expected growth rate. Historically, Flowserve's trailing P/E has ranged from as low as 7.86x (Q3 2025) to as high as 58.85x (Q4 2021). The current 26.08x is near the middle of this range, indicating it is not at extreme levels. However, the forward P/E of 14.83x is near the lower end of historical forward multiples, suggesting the market is pricing in a normalization of earnings after the recent volatility. The price-to-book ratio of 4.12x is above the historical average of around 2.5-3.0x, implying a premium that may be justified by the company's strong ROE and market position.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 21x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Flowserve's revenue decline of 6.66% YoY in Q1 2026 and volatile earnings (net income swung from -$29.0M in Q4 2025 to $81.7M in Q1 2026) highlight its cyclical exposure. The company's debt-to-equity of 0.80 is manageable, but negative free cash flow of -$60.0M in Q1 2026 due to working capital changes could pressure liquidity if sustained. Margins are improving (gross margin 37.1%), but reliance on large project awards makes revenue lumpy and unpredictable.
Market & Competitive Risks: With a beta of 1.247, FLS is 25% more volatile than the market, amplifying downside in a selloff. The stock's trailing P/E of 26.08x is above the broader market, leaving it vulnerable to multiple compression if growth disappoints. The recent downgrade from TD Cowen (Buy to Hold on June 24, 2026) signals shifting sentiment, and the wide spread between analyst targets ($70 low to $100 high) reflects high uncertainty. Competitive pressures from other flow control providers could also pressure margins.
Worst-Case Scenario: A prolonged industrial downturn could cause revenue to contract further, margins to compress, and earnings to fall short of estimates. In this scenario, the stock could decline to its 52-week low of $48.71, representing a 28.9% loss from the current price of $68.46. Historical max drawdown of -30.04% suggests similar downside is possible, especially if the company reports another negative EPS quarter.
FAQ
The key risks are: (1) Cyclical downturn risk: revenue declined 6.66% YoY in Q1 2026, and a prolonged industrial slump could further pressure earnings. (2) Earnings volatility: net income swung from -$29.0M in Q4 2025 to $81.7M in Q1 2026, making earnings unpredictable. (3) Valuation risk: the trailing P/E of 26.08x leaves little room for error if growth disappoints. (4) Market risk: with a beta of 1.247, the stock is more volatile than the market, amplifying losses in a downturn. The most severe risk is a recession causing a drop to the 52-week low of $48.71, a 28.9% loss.
The 12-month forecast is moderately bullish. The base case (45% probability) sees the stock trading between $75 and $88, aligning with the average analyst target of $88.50, assuming gradual revenue recovery. The bull case (30% probability) targets $85-$100, driven by strong margin expansion and project wins. The bear case (25% probability) sees the stock falling to $50-$70, possibly testing the 52-week low of $48.71, if the downturn deepens. The most likely scenario is the base case, with gradual improvement in end-markets.
On a trailing basis, FLS appears fairly valued to slightly overvalued with a P/E of 26.08x, but on a forward basis, it is undervalued with a P/E of 14.83x, reflecting expected earnings growth. The PEG ratio of 1.10 suggests fair value relative to growth. The price-to-book ratio of 4.12x is above historical averages of 2.5-3.0x, indicating a premium on book value, but this is justified by a strong ROE of 15.8%. Overall, the stock is undervalued based on forward earnings and analyst targets, but not a deep value play.
FLS appears to be a good buy for investors with a 12-month horizon, given the analyst consensus Buy rating and 29.3% upside to the average target of $88.50. The forward P/E of 14.83x is attractive relative to the trailing 26.08x, implying expected earnings growth. However, the recent revenue decline of 6.66% YoY and negative price momentum (-13.26% in 1 month) introduce risk. The stock is best suited for those who can tolerate cyclical volatility and believe in a recovery in industrial demand. For conservative investors, waiting for confirmation of revenue stabilization may be prudent.
FLS is more suitable for long-term investment (12-24 months) due to its cyclical nature and current pullback. The stock has a beta of 1.247, making it volatile for short-term trading. The dividend yield of 1.22% provides some income, but the payout ratio of 31.7% is sustainable. For long-term investors, the forward P/E of 14.83x offers a reasonable entry point if they believe in a multi-year recovery. Short-term traders may find opportunities in mean reversion, but the negative momentum (-13.26% in 1 month) suggests caution. A minimum holding period of 12 months is recommended to allow for cyclical recovery.